C2 C Wealth Management, LLC Puma Biotechnology, Inc. Transaction History
C2 C Wealth Management, LLC
- $106 Million
- Q1 2025
A detailed history of C2 C Wealth Management, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, C2 C Wealth Management, LLC holds 15,150 shares of PBYI stock, worth $51,207. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,150
Previous 12,000
26.25%
Holding current value
$51,207
Previous $36,000
22.22%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding PBYI
# of Institutions
116Shares Held
30.9MCall Options Held
32.7KPut Options Held
200-
Acorn Capital Advisors, LLC New York, NY3.94MShares$13.3 Million8.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$12.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$12.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$6.79 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.83MShares$6.18 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $154M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...